文献速递肝病

线粒体丙酮酸载体1调控脂肪酸合酶乳酰化并介导非酒精性脂肪性肝病治疗

Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease.
PubMed 文献 · Hepatology · 2023-01-19

研究检测正常对照与NAFLD患者肝组织中MPC1表达,发现MPC1表达与肝脂质沉积正相关;MPC1+/-小鼠高脂饮食后肝脂质积累减少但脂质合成基因表达无变化;MPC1敲除通过调节乳酸水平影响脂肪酸合酶K673位点乳酰化,抑制脂肪酸合酶活性,从而下调肝脂质积累,且炎症水平因线粒体保护和巨噬细胞极化而得到控制。

要点

  • NAFLD患者肝组织中MPC1表达与肝脂质沉积正相关。
  • MPC1+/-小鼠高脂饮食后肝脂质积累减少,但脂质合成相关基因表达无变化。
  • 脂肪酸合酶K673位点乳酰化抑制其活性,介导MPC1敲除下调肝脂质积累。

核心结论

  • 在NAFLD中,MPC1水平与肝脂质沉积正相关;脂肪酸合酶K673位点乳酰化增强可能是下游机制。

研究设计与样本

  • 研究检测正常对照和NAFLD患者肝组织MPC1表达,并表征MPC1全身杂合敲除(MPC1+/-)小鼠的代谢表型及肝脂质积累相关基因表达。
  • 采用串联质谱标签蛋白质组学检测肝蛋白乳酰化,并通过细胞中乳酰化突变体过表达验证。
  • 在小鼠和AML-12细胞中检测MPC1抑制对肝炎症的影响。

主要发现

  • MPC1表达与NAFLD患者肝脂质沉积正相关。
  • MPC1+/-小鼠高脂饮食后肝脂质积累减少,但脂质合成相关基因表达无变化。
  • MPC1敲除通过调节肝细胞乳酸水平影响多种蛋白乳酰化,尤其是脂肪酸合酶。
  • 脂肪酸合酶K673位点乳酰化抑制脂肪酸合酶活性,介导MPC1敲除下调肝脂质积累。
  • MPC1敲除导致乳酸积累,但炎症水平因线粒体保护和巨噬细胞极化而得到控制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出MPC1对NAFLD相关肝脂质代谢的影响及其在NAFLD进展中的作用需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: NAFLD has become a major metabolic disease worldwide. A few studies have reported the potential relationship between mitochondrial pyruvate carrier 1 (MPC1) and inflammation, fibrosis, and insulin sensitivity in obese or NASH mouse models. However, the impact of MPC1 on NAFLD-related liver lipid metabolism and its role in the NAFLD progression require further investigation. APPROACH AND RESULTS: MPC1 expression was measured in liver tissues from normal controls and patients with NAFLD. We characterized the metabolic phenotypes and expression of genes involved in hepatic lipid accumulation in MPC1 systemic heterozygous knockout (MPC1 +/- ) mice. Hepatic protein lactylation was detected using Tandem Mass Tags proteomics and verified by the overexpression of lactylation mutants in cells. Finally, the effect of MPC1 inhibition on liver inflammation was examined in mice and AML-12 cells. Here, we found that MPC1 expression was positively correlated to liver lipid deposition in patients with NAFLD. MPC1 +/- mice fed with high-fat diet had reduced hepatic lipid accumulation but no change in the expression of lipid synthesis-related genes. MPC1 knockout affected the lactylation of several proteins, especially fatty acid synthase, through the regulation of lactate levels in hepatocytes. Lactylation at the K673 site of fatty acid synthase inhibited fatty acid synthase activity, which mediated the downregulation of liver lipid accumulation by MPC1. Moreover, although MPC1 knockout caused lactate accumulation, inflammation level was controlled because of mitochondrial protection and macrophage polarization. CONCLUSIONS: In NAFLD, MPC1 levels are positively correlated with hepatic lipid deposition; the enhanced lactylation at fatty acid synthase K673 site may be a downstream mechanism.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Gao R, Li Y, Xu Z, et al. Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease. Hepatology. 2023. PMID: 36651176. doi:10.1097/HEP.0000000000000279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。